-

Germany Wind Power Market Report 2020-2025: COVID-19 Implications - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Germany Wind Power Market Outlook to 2025" report has been added to ResearchAndMarkets.com's offering.

Even as the wind power generation technology is now relatively advanced, the industry is reaching a stage of maturity in the key markets, with some other markets still evolving.

In 2019, around 60.4 GW of new wind power capacity was added globally, making it the second-largest year in history and close to the largest year in 2015 (63.8 GW), bringing global cumulative wind power capacity up to 651 GW. The massive wind turbine installation was primarily the result of a strong year in both China and the US: the world's two largest markets ahead of the expiry of Feed-in Tariffs (FiT) for onshore in the first country and the PTC (extended until the end of 2020 in Dec 2019) in the second.

This report report provides comprehensive market analysis on the historical development and targets, the current state of wind power installation scenario, and its outlook. The insights in the research report: market data, policies and regulations, project data, company profiles, and competitive landscape analysis - have been derived primarily from our proprietary databases, and offerings.

The report discusses the impact of the ongoing COVID-19 pandemic on the wind power market, economic trends, and investment and financing scenario in Germany. It gives insights into the market dynamics and the challenges of wind power development in the country. It also comprises significant market development trends and highlights how the socio-economic, environmental, and political factors affect the nation's wind market.

Besides, the report looks into the current state and assesses the potential for the future growth of onshore and offshore wind power development.

Key Topics Covered

1. Executive Summary

2. Research Scope and Methodology

3. Market Analysis

3.1 Introduction

3.2 Market Dynamics

3.2.1. Drivers

3.2.2 Restraints

3.3 Market Trends & Developments

3.4 Market Opportunities

3.5 Key Projects

3.6 Government Policies and Regulations

4. Market Outlook

4.1 Annual Wind Power Installed Capacity, 2001-2025, in GW

4.2 Cumulative Wind Power Installed Capacity Forecast, 2001-2025, in GW

5. Business Activity Analysis

5.1 Supply Chain Analysis

5.2 PESTLE Analysis

6. Market Segmentation & Analysis

6.1 By Location

6.1.1 Onshore

6.1.2 Offshore

7. Competitive Landscape

7.1 List of Notable Players in the Market

7.2 M&A, JV, and Agreements

7.3 Strategies of Key Players

8. Key Company Profiles

9. Conclusions and Recommendations

Companies Mentioned

  • Vestas Wind Systems A/S
  • Nordex Group
  • GE Renewable Energy (General Electric Company)
  • Siemens Gamesa Renewable Energy (SGRE)
  • Senvion
  • MHI Vestas Offshore Wind A/S

For more information about this report visit https://www.researchandmarkets.com/r/29etou

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th - Mar 26th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries....

European Union Veterinary Pharmacovigilance Introductory Training Course: Practical Guidance and Basic Training for All Those Working in Drug Safety (Mar 9th - Mar 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to Veterinary Pharmacovigilance Training Course (Mar 9th - Mar 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day event has been designed to provide an essential overview of veterinary pharmacovigilance and will offer practical guidance and basic training for all those working in drug safety in the EU. Our experienced trainer will clarify roles and responsibilities, explain commonly used terminology and take partici...

Pharma and Medical Device Clinical Quality Management Systems Training Course: EMA Guidance on Computerised Systems and ICH GCP R3 Data Governance (Mar 23rd - Mar 24th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Quality Management Systems Training Course (Mar 23rd - Mar 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will provide essential information and guidance to help you achieve regulatory compliance in this evolving area of clinical quality, including EMA guidance on computerised systems and ICH GCP R3 data governance. With increasing clinical quality standards required by inspectors, there is currently no harmonised re...
Back to Newsroom